Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital Tuebingen |
---|---|
Information provided by: | University Hospital Tuebingen |
ClinicalTrials.gov Identifier: | NCT00734721 |
Condition | Intervention | Phase |
---|---|---|
Age-Related Macular Degeneration Stress |
Behavioral: Preoperative information and perioperative care |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment |
Official Title: | Fear of Intravitreal Injection - Assessment of Psychological Strain and Potential Contributing Factors |
Estimated Enrollment: | 60 |
Study Start Date: | December 2007 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Active Comparator
Presentation of factual information video
|
Behavioral: Preoperative information and perioperative care
Patients receive different information and care in addition to the basic medical consultation.
|
B: Active Comparator
Presentation of injection syringe/needle
|
Behavioral: Preoperative information and perioperative care
Patients receive different information and care in addition to the basic medical consultation.
|
C: Active Comparator
Presentation of emotional information video
|
Behavioral: Preoperative information and perioperative care
Patients receive different information and care in addition to the basic medical consultation.
|
D: Active Comparator
Stress relaxation music
|
Behavioral: Preoperative information and perioperative care
Patients receive different information and care in addition to the basic medical consultation.
|
The aim of the study is to assess the influence of perioperative factors on objective outcome measures, which indicate the physiologic stress reaction.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Focke Ziemssen, MD | 0049 7071 29 84761 | Focke.Ziemssen@med.uni-tuebingen.de |
Contact: Karl U Bartz-Schmidt, MD | 0049 7071 29 84001 |
Germany, BW | |
University Eye Hospital | Recruiting |
Tuebingen, BW, Germany, 72076 | |
Contact: Focke Ziemssen, MD 0049 7071 29 84761 Focke.Ziemssen@med.uni-tuebingen.de | |
Principal Investigator: Focke Ziemssen |
Responsible Party: | University Eye Hospital Tuebingen ( Ziemssen/Dr ) |
Study ID Numbers: | UEH-2007FIV |
Study First Received: | August 13, 2008 |
Last Updated: | August 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00734721 History of Changes |
Health Authority: | Germany: Ethics Commission |
intravitreal injection |
Eye Diseases Retinal Degeneration Stress Macular Degeneration Retinal Diseases |
Eye Diseases Retinal Degeneration Macular Degeneration Retinal Diseases |